Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Survivorship Research
100%
Cancer Therapy
75%
Clinical Trials
43%
Grant Funding
37%
Clinical Investigator
37%
Symptom Control
37%
Control Program
37%
Clinical Research
35%
Oncology
35%
Mayo Clinic
31%
Program Research
25%
Community Clinical Oncology Program
25%
Treatment Group
18%
Cancer Treatment
18%
Patient Care
18%
Cancer Prevention
18%
Cancer Control
18%
North Central
18%
Review Process
18%
Mentorship
18%
Control Research
18%
Prevention Programs
18%
Comprehensive Cancer Center
18%
Protocol Review
18%
On-the-job Training
18%
Specific Aims
18%
Early Career
18%
Succession Planning
18%
Patients with Cancer
18%
Principal Investigator
18%
Cancer Control Program
18%
Tumor Antigen
16%
Cancer Center
16%
Tumor Cells
16%
Cell-based
16%
Augmentation Strategy
16%
Scientific Abstracts
12%
Training Approaches
12%
Scientific Manuscript
12%
CD40 Ligand
8%
Therapeutic Vaccine
8%
Conventional Treatment
8%
Protected Time
8%
Senior Leaders
8%
Research Laboratories
8%
Accruals
8%
Immunological Effects
8%
Regulatory T (Treg) Cells
8%
Immunology
8%
Hematology
8%
Novel Treatments
8%
Investigator-initiated
8%
Immunotherapeutics
8%
Treatment Modalities
8%
Mentee
8%
Bystander Cells
8%
Clinical Research Training
8%
T Cell Proliferation
8%
Associate Professor
8%
Granulocyte Colony-stimulating Factor (G-CSF)
8%
Surgical Oncology Fellowship
8%
Clinical Volume
8%
Administrative Responsibility
8%
Lung Cancer Patients
8%
Clinical Effect
8%
Clinic Visits
8%
Program Directors
8%
Research Scientist
8%
Scientific Hypothesis
8%
Clinical Mentoring
8%
IDO Inhibitor
8%
IND Application
8%
Regulatory Agencies
8%
Fellowship Training
8%
1-methyltryptophan
8%
Gene-modified
8%
Early Phase Clinical Trials
8%
Steady Growth
8%
Immunomodulatory Effect
8%
Lymphodepletion
8%
Healthcare Quality Improvement
6%
Medicine and Dentistry
Malignant Neoplasm
41%
Clinical Research
30%
Clinical Trial
30%
Cancer Therapy
25%
Immunotherapy
25%
Oncology
21%
Tumor Antigen
16%
Tumor Cell
16%
Cancer
16%
Treatment Modality
16%
Clinical Oncology
10%
Base
10%
Surgical Oncology
8%
Dendritic Cell Vaccine
8%
Hematology
8%
8 Difluoromethoxy 1 Ethyl 6 Fluoro 1,4 Dihydro 7 [4 (2 Methoxyphenyl) 1 Piperazinyl] 4 Oxo 3 Quinolinecarboxylic Acid
8%
Tumor Vaccine
8%
Indoleamine 2,3 Dioxygenase Inhibitor
8%
Granulocyte Macrophage Colony Stimulating Factor
8%
T Cell Proliferation
8%
Protein P53
8%
Cell Line
8%
Lung Cancer
8%
Immunology
8%
Immunosuppressive Drug
8%
N Methyltryptophan
8%
CD40 Ligand
8%
Cancer Control
5%
Cancer Prevention
5%
Treatment Group
5%
Nursing and Health Professions
Cancer Therapy
75%
Malignant Neoplasm
60%
Cancer Control
30%
Base
20%
Prevention and Control
15%
Cancer Prevention
15%
Treatment Group
15%
Cancer Center
15%
Clinical Trial
15%
Economic and Social Development
10%